about
Epithelial Sodium and Chloride Channels and AsthmaExpression of mRNA IL-17F and sIL-17F in atopic asthma patients.The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo.Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly.Obstructive Sleep Apnoea Modulates Airway Inflammation and Remodelling in Severe Asthma.Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model.Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.USP17-mediated deubiquitination and stabilization of HDAC2 in cigarette smoke extract-induced inflammationThe immunoregulatory and fibrotic roles of activin A in allergic asthmaMonoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.Differential connectivity of gene regulatory networks distinguishes corticosteroid response in asthma.Clinical implications of omics and systems medicine: focus on predictive and individualized treatment.Interaction Between Helminths and Toll-Like Receptors: Possibilities and Potentials for Asthma Therapy.Effect of roflumilast on airway remodelling in a murine model of chronic asthma.Nuclear bioavailability of the glucocorticoid receptor in a pediatric asthma cohort with variable corticosteroid responsiveness.Biologic therapy in the management of asthma.Alternative approaches for the treatment of airway diseases: focus on nanoparticle medicine.Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo.Drug Repurposing to treat Asthma and Allergic Disorders: Progress and Prospects.Epigenetic regulation of T-helper cell differentiation, memory, and plasticity in allergic asthma.Editorial: leukocyte-targeting toxins as therapeutics in allergic asthma.Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner.Asthma biomarkers in the age of biologics.Transcriptional regulation on the gene expression signature in combined allergic rhinitis and asthma syndrome.Influence of an Allergen-Specific Th17 Response on Remodeling of the Airways.Pharmacogenetics of steroid-responsive acute graft-versus-host disease.Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma.Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.The Plant Proteinase Inhibitor Plays a Role in Controlling Asthma Response in MiceFra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent Manner
P2860
Q26799074-327BF0CE-0694-495E-9EC4-8337C5BF0910Q33791913-87287648-6E31-4722-BD40-A5CD5D3F3189Q33922498-D6AF0102-4FE0-465F-8DEB-8655C9437E73Q35765263-89B79642-96A2-49E3-AEF5-5CC430F48596Q35942780-51A19D54-C52D-4D2A-BB7C-006AE39C3418Q36081902-5A7F9A86-3C72-4F7A-8F75-34104A826FD0Q36183922-E462E42C-725C-4417-AB14-01B8337AFD80Q36261506-ACCC7859-319C-44C1-9936-47606264FD50Q36393944-195ECD1F-E5FA-4039-A709-7A537B9E87ADQ36599623-C580DC14-6838-434B-931E-9AFF69E9548AQ38430805-69DCF819-DE6D-4F71-BA3C-3B285E1876D4Q38739645-1E469F31-0FBD-4813-8CC0-71812D30B1FAQ38819029-CAB63C54-886C-42B0-951F-AE45242A1600Q38821694-9815D4B7-5805-452E-86A1-47AA208DE881Q38844013-23A0CAC8-0A07-454A-BC0A-59CE16E3996EQ38846809-50643EEF-8C26-44B2-8E77-6366AED4FC1EQ38893756-FEB0E315-5A0B-429D-9727-B7214EF7C4C1Q39134695-6F43B071-0231-4E83-BCF6-43399B6614B0Q39150081-0E92B06E-DB1E-4877-AE70-70D4946A3ED0Q39402920-102CD6C1-09FE-43C8-9D49-CEEF96A6E2BBQ42336260-B75D2671-7019-4A73-8189-0AA8FA5D809BQ42784201-8CAA5A65-5B01-4609-84D2-F111061DB7B0Q47169950-2F9C0777-59C0-4269-B8C2-7172EC1CFC12Q47656886-41D71A24-6379-4B6C-80E9-8C3B56BB3A16Q48153081-25ED24B5-4D5D-4701-A40E-8E53479A720EQ48156098-C6714A96-F40D-43CE-922A-22208A6E5D2AQ51654211-D608CC07-1D51-4C36-A591-BE96300C9D3DQ52372449-D8FE4DDD-DCA5-4372-A7BF-E1AB6836B406Q58589064-DA59A232-D513-47CF-A5C5-F12F65A32B51Q58763011-934C727E-811D-401B-80DF-403E3A81B378
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Refractory asthma: mechanisms, targets, and therapy.
@ast
Refractory asthma: mechanisms, targets, and therapy.
@en
Refractory asthma: mechanisms, targets, and therapy.
@nl
type
label
Refractory asthma: mechanisms, targets, and therapy.
@ast
Refractory asthma: mechanisms, targets, and therapy.
@en
Refractory asthma: mechanisms, targets, and therapy.
@nl
prefLabel
Refractory asthma: mechanisms, targets, and therapy.
@ast
Refractory asthma: mechanisms, targets, and therapy.
@en
Refractory asthma: mechanisms, targets, and therapy.
@nl
P2860
P356
P1433
P1476
Refractory asthma: mechanisms, targets, and therapy.
@en
P2093
J L Trevor
J S Deshane
P2860
P304
P356
10.1111/ALL.12412
P577
2014-04-29T00:00:00Z
2014-07-01T00:00:00Z